Page 15 - Pfizer
Pfizer shares hit record high with Covid-19 vaccine stocks on a tear
The percentage gain was the stock's biggest one-day rise since Nov. 9, when Pfizer released positive data for its Covid-19 vaccine
 "Pfizer shares hit record high with Covid-19 vaccine stocks on a tear")
BioNTech says has supplied more than 1 billion Covid vaccine doses so far
BioNTech and partner Pfizer have supplied more than one billion doses of their vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca the German biotech Group said
 "BioNTech says has supplied more than 1 billion Covid vaccine doses so far")
J&J seeks approval for single-dose Covid-19 vaccine in India
It is not clear whether J&J is seeking indemnity against adverse events following vaccination like its US peers
 "J&J seeks approval for single-dose Covid-19 vaccine in India")
Pfizer, Moderna raise prices for Covid-19 vaccines in European Union
The terms of the deals were renegotiated after Phase 3 clinical trial data showed vaccines from the two companies are more effective than some rivals
 "Pfizer, Moderna raise prices for Covid-19 vaccines in European Union")
India may soon have Covid-19 vaccines for children. All you need to know
Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above
 "India may soon have Covid-19 vaccines for children. All you need to know")
World Coronavirus Dispatch: Israel offers Pfizer booster jab to the 60-plus
China says it has made alternative proposal for virus origin probe, EU pulls ahead of US in vaccinations, and other pandemic-related news across the globe
 "World Coronavirus Dispatch: Israel offers Pfizer booster jab to the 60-plus")
Pfizer raises sales forecast for Covid vaccine by almost a third to $33 bn
The New York drugmaker had previously projected vaccine sales for the year of $26 billion.
 "Pfizer raises sales forecast for Covid vaccine by almost a third to $33 bn")
Top headlines: Pfizer raises sales forecast; Maruti misses estimates in Q1
Business Standard brings you the top headlines on Wednesday
Pfizer, Astra vaccine antibody levels may decline after 2-3 months: Lancet
Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to The Lancet journal
 "Pfizer, Astra vaccine antibody levels may decline after 2-3 months: Lancet")
Covid LIVE: Delhi records zero fatality, 2nd time since onset of 2nd wave
The number of people who have recuperated from the disease has surged to 30,503,166, while the case fatality rate stands at 1.34 per cent
 "Covid LIVE: Delhi records zero fatality, 2nd time since onset of 2nd wave")
US to buy 200 million more doses of Pfizer vaccine, says White House
The federal government is buying 200 million more doses of the Pfizer coronavirus vaccine to prepare for future needs, such as boosters and shots for kids under 12
 "US to buy 200 million more doses of Pfizer vaccine, says White House")
No domestic vaccine maker has sought indemnity: Junior Health Minister
Bharti Pravin Pawar says Centre has set up team to deal with various issues related to procurement of Covid-19 vaccine from foreign firms
 "No domestic vaccine maker has sought indemnity: Junior Health Minister")
Discussing indemnity, other issues with foreign Covid vaccine makers: Govt
A team of central government officials is in continuous dialogue with foreign Covid vaccine manufactures like Pfizer, Moderna and Johnson and Johnson to discuss and address various issues
 "Discussing indemnity, other issues with foreign Covid vaccine makers: Govt")
Biovac-Pfizer collaboration a breakthrough for Covid in Africa: Ramaphosa
Ramaphosa has welcomed the announcement of a collaboration between the country's Biovac Institute and US pharma giant Pfizer as a breakthrough in the protection of African nations against COVID
 "Biovac-Pfizer collaboration a breakthrough for Covid in Africa: Ramaphosa")
Small contract manufacturers wait to take a shot at Covid vaccines
A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors
 "Small contract manufacturers wait to take a shot at Covid vaccines")
Pfizer to discuss Covid-19 vaccine booster with US officials today
Pfizer says it plans to meet with top US health officials Monday to discuss the drugmaker's request for federal authorization of a third dose of its Covid-19 vaccine
 "Pfizer to discuss Covid-19 vaccine booster with US officials today")
Pfizer Covid-19 vaccine booster dose plan sparks controversy in US
The announcement by US drugmaker Pfizer of a plan on developing a booster dose of its Covid-19 vaccine has heightened hesitancy amongst unvaccinated population and sparked confusion across country
Covid-19 pandemic: Pfizer seeks US regulator's nod for booster shot
FDA and EU regulator say no need for extra dosage at this time
Pfizer to seek US nod for third dose of Covid-19 vaccine to boost immunity
Pfizer is about to seek US authorisation for a third dose of its Covid-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity
 "Pfizer to seek US nod for third dose of Covid-19 vaccine to boost immunity")
4 million doses of Pfizer, Moderna likely through COVAX by August
Indemnity issue to be settled to bring the two US vaccines through COVAX
 "4 million doses of Pfizer, Moderna likely through COVAX by August")